Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...

Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients ...

Hypertension is a major global health issue. Aldosterone synthase inhibitors (ASIs) have emerged as a promising therapeutic strategy for blood pressure control. A thorough search of the MEDLINE and ...

we examined plasma renin activity (PRA), aldosterone levels, and other blood chemistries during high and low dietary salt intake in 30 human subjects with widely different coronary disease risk. Our ...

The symptoms of hyperkalemia begin with muscle weakness. As serum potassium levels rise, symptoms progress to more significant muscle twitching, weakness, nausea, and cramping. [69] Cardiac ...

Research suggests that vitamin D plays a role in regulating the renin-angiotensin-aldosterone system (RAAS), a critical pathway involved in blood pressure regulation. Vitamin D has been shown to ...